47 min listen
Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby
Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby
ratings:
Length:
70 minutes
Released:
May 9, 2023
Format:
Podcast episode
Description
In this episode, Anthony and Bernie are joined once again by special guest and hematology expert, Dr. Dale Bixby, to discuss the recent publication of the QUANTUM-First study of quizartinib in newly diagnosed AML. Should this study change practice in FLT3-ITD+ AML? Have we made a "Quantum Leap" in the treatment of these patients? Listen for a fun-filled discussion of the data!
Notable References:
QUANTUM-First Study: https://pubmed.ncbi.nlm.nih.gov/37116523/
WolverHeme Episode 8 (Pulling the Goalie on FLT3 Inhibitor Use in AML): https://podcasters.spotify.com/pod/show/wolverheme/episodes/Episode-8-Pulling-the-Goalie-on-FLT3-Inhibitor-Use-in-AML---A-Discussion-with-Dr--Dale-Bixby-e1r6tqt/a-a8tthkc
Notable References:
QUANTUM-First Study: https://pubmed.ncbi.nlm.nih.gov/37116523/
WolverHeme Episode 8 (Pulling the Goalie on FLT3 Inhibitor Use in AML): https://podcasters.spotify.com/pod/show/wolverheme/episodes/Episode-8-Pulling-the-Goalie-on-FLT3-Inhibitor-Use-in-AML---A-Discussion-with-Dr--Dale-Bixby-e1r6tqt/a-a8tthkc
Released:
May 9, 2023
Format:
Podcast episode
Titles in the series (25)
Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone by WolverHeme Happy Hour